C2E: 9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one)
C2E is a Ligand Of Interest in 3GFY designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
3GFY_C2E_A_501 | 66% | 6% | 0.143 | 0.948 | 3.39 | 1.76 | 10 | 14 | 1 | 1 | 100% | 1 |
3GFY_C2E_B_501 | 63% | 6% | 0.142 | 0.939 | 3.4 | 1.79 | 10 | 13 | 1 | 1 | 100% | 1 |
3GG1_C2E_B_501 | 78% | 6% | 0.107 | 0.949 | 3.32 | 1.71 | 10 | 15 | 1 | 1 | 100% | 1 |
3GFX_C2E_A_501 | 74% | 6% | 0.123 | 0.952 | 3.37 | 1.78 | 10 | 13 | 0 | 1 | 100% | 1 |
3GG0_C2E_A_501 | 67% | 7% | 0.138 | 0.948 | 3.38 | 1.57 | 10 | 12 | 2 | 1 | 100% | 1 |
3GFZ_C2E_B_501 | 67% | 6% | 0.109 | 0.916 | 3.2 | 1.94 | 11 | 18 | 1 | 1 | 100% | 1 |
8U0I_C2E_A_102 | 100% | 40% | 0.042 | 0.984 | 1.15 | 1.19 | 6 | 6 | 0 | 0 | 100% | 1 |
4RT1_C2E_B_201 | 99% | 17% | 0.054 | 0.982 | 2.38 | 1.24 | 11 | 7 | 0 | 0 | 100% | 1 |
4URG_C2E_A_1241 | 97% | 16% | 0.065 | 0.983 | 2.24 | 1.49 | 10 | 10 | 0 | 0 | 100% | 1 |
2RDE_C2E_B_301 | 97% | 45% | 0.067 | 0.983 | 0.93 | 1.18 | 2 | 6 | 1 | 0 | 100% | 1 |
8WJD_C2E_A_201 | 97% | 57% | 0.055 | 0.97 | 0.99 | 0.68 | 2 | - | 0 | 0 | 100% | 0.42 |